Literature DB >> 1291320

Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae.

L J Piddock1, H L Turner.   

Abstract

The activity of meropenem against 106 imipenem-resistant (MIC > or = 8 mg/l) clinical isolates, and the frequency of resistance to meropenem and imipenem among 24 Enterobacteriaceae was determined. Both agents selected colonies on agar but 20-80% were susceptible after one subculture and 72% of the mutants reverted to susceptibility 1 to 6 months after selection. All isolates and stable mutants were inhibited by > 1 mg/l meropenem, although the MIC of imipenem was 4-16 mg/l. Three of six Xanthomonas maltophilia isolates were susceptible to meropenem (MICs 2-4 mg/l). Pseudomonas aeruginosa lacking outer membrane protein D2 were resistant to meropenem, although isolates with substantially reduced expression of this protein were susceptible. None of the imipenem-resistant gram-positive bacteria were susceptible to meropenem. There was no clear correlation between altered outer membrane protein expression and decreased susceptibility to carbapenems, and there was no apparent involvement of plasmid or chromosomal beta-lactamase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1291320     DOI: 10.1007/bf01961143

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.

Authors:  L J Piddock; M C Hall; R N Walters
Journal:  J Antimicrob Chemother       Date:  1991-08       Impact factor: 5.790

2.  A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.

Authors:  L J Piddock; E A Traynor; R Wise
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790

3.  Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.

Authors:  C Chanal; D Sirot; M Chanal; M Cluzel; J Sirot; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

4.  Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.

Authors:  C C Sanders; W E Sanders; K S Thomson; J P Iaconis
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

5.  Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom.

Authors:  A King; C Boothman; I Phillips
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

6.  Interactions of meropenem with class I chromosomal beta-lactamases.

Authors:  Y J Yang; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

7.  Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.

Authors:  D M Livermore; Y J Yang
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

8.  In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338.

Authors:  Y Sumita; M Inoue; S Mitsuhashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

9.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

10.  Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.

Authors:  E H Lee; M H Nicolas; M D Kitzis; G Pialoux; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

View more
  6 in total

1.  Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.

Authors:  L Martínez-Martínez; A Pascual; S Hernández-Allés; D Alvarez-Díaz; A I Suárez; J Tran; V J Benedí; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

2.  Resistance and tolerance to tropodithietic acid, an antimicrobial in aquaculture, is hard to select.

Authors:  Cisse Hedegaard Porsby; Mark A Webber; Kristian Fog Nielsen; Laura J V Piddock; Lone Gram
Journal:  Antimicrob Agents Chemother       Date:  2011-01-24       Impact factor: 5.191

Review 3.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.

Authors:  C Gimeno; D Navarro; F Savall; E Millás; M A Farga; J Garau; R Cisterna; J García-de-Lomas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

5.  Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates.

Authors:  Christine D Steward; Jasmine M Mohammed; Jana M Swenson; Sheila A Stocker; Portia P Williams; Robert P Gaynes; John E McGowan; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

6.  Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.

Authors:  J C Fung-Tomc; E Gradelski; B Kolek; B Minassian; M Pucci; R E Kessler; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.